Anzeige
Mehr »
Login
Mittwoch, 18.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Der Markt erwartet spektakuläre News, welche diese Aktie sofort explodieren lassen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
409 Leser
Artikel bewerten:
(2)

Care Fertility Group expands its international footprint to the US and Spain

Finanznachrichten News

NOTTINGHAM, England, Dec. 13, 2022 /PRNewswire/ -- Care Fertility has today announced new partnerships with the US based Reach Fertility and Spanish based IVF-Life. These are the latest of several fertility clinic transactions by Care Fertility, a leading IVF group in the UK and one of the leaders globally in the treatment of infertility.

Care Fertility, backed by private equity investor Nordic Capital, has a reputation for innovation, clinical excellence, a unique patient proposition and delivering strong success rates for all patients.

Dr. Seth Katz, the medical director at REACH Fertility says, "this partnership is a reflection of our shared vision and values with Care Fertility and we look forward to enhancing access to innovative care and cutting-edge reproductive medicine for all our patients."

The partnerships with REACH Fertility, IVF-Life and Integrated Genetic Laboratory Services (IGLS) will enable Care to leverage its expertise, innovation and outstanding patient care across international markets. Despite the global economic challenges, the demand for fertility treatment remains strong. This is largely due to rising infertility cases and an increasing trend of delaying pregnancy for various reasons.

"OurSpanish partnership delivers an exciting opportunity for both Care Fertility, IVF-Life and IGLS to give patients a seamless experience across borders, whilst the essence of the US partnership is the creation of key synergies and the opportunity to bring some of Care's unique innovations to the US market," explains David Burford, CEO of Care Fertility group.

Dr. Jon Aizpurua, President and founder of IVF-Life and IGLS comments: "We are confident that the synergies between Care Fertility, IVF-Life and IGLS, will contribute to the worldwide expansion of our footprint in the assisted reproduction market by offering an increasingly wider scope of personalized fertility treatments, facilitating the continuous development of ground-breaking solutions for patients across the globe."

Over the last twenty-five years, patients have travelled from around the world to access treatment at some of Care's world-leading clinics in the UK. Care's expansion to the US and Spain provides an important first step in delivering greater accessibility for international patients. In addition, the partnership with IGLS will enhance Care's provision of genetic and immunology solutions for the whole IVF treatment pathway.

"Nordic Capital is delighted to support this exciting new stage in Care Fertility's growth. We see it as an opportunity to access key new markets and leverage the underlying tools, platform and innovation that Care Fertility have created. We welcome IVF-Life, IGLS and REACH Fertility to the Care Fertility Group," Alfa Chan, Partner, Nordic Capital Advisors.

For further information, please contact:

Alison Weatherall, Marketing Director, Care Fertility Group
Alison.weatherall@carefertility.com
Mobile: +44 7530 290703

About:

Care Fertility

Care Fertility is an international fertility group, focused on innovation, clinical excellence and market leading patient proposition with strong success rates. Over the last 25 years, Care Fertility scientists and clinicians have driven many of the innovations in the field of IVF and their continuous clinical improvement is supported by and recognised through international collaborations and publications. Their current work on time-lapse imaging and artificial intelligence is shared internationally.

Inclusivity is at the core of Care's culture, with a brand promise of Family is for everyone, they continue to build a culture where everyone belongs and empathy is shown for all groups. It is this blended coalescence of empathy and scientific excellence that makes Care different.

Care Fertility has links with various academic institutions and leads the field in training of specialist staff. They have established a Masters degree in clinical embryology in collaboration with Liverpool John Moore's University.

Care Fertility sits as one of six international experts on the World Health Organisation's focus group to specify standardised benchmarks and guidelines for AI within human reproduction and fertility systems.

Care Fertility is the largest independent provider of fertility treatments in the UK, with 23 clinics across the UK and Ireland.

www.carefertility.com

REACH Fertility

The Reproductive Endocrinology Associates of Charlotte (REACH) has been a leader in assisted reproduction for over three decades. Located in North Carolina, REACH has achieved some of the highest pregnancy rates in the Southeast of the US.

The practice's infertility specialists-Dr. Seth E. Katz, Dr. Joseph G. Whelan, III, Dr. Richard L. Wing, Dr. Jack L. Crain, Dr. Tyl Taylor, Dr. Jennifer Patrick, Taylor Holt, PA-C, Ann Morris Merline, PA-C, Grace Perez, PA-C and Daminica Mc Phillips, NP- BC have more than 130 years of combined experience, and are nationally recognized as leaders in the field.

www.northcarolinafertility.com

IVF-Life

IVF-Life Spain is a group of fertility clinics which specialise in complex cases. Their centres, located in Alicante, Madrid and San Sebastián, have the latest advances in Reproductive Medicine. They focus on constant innovation and a firm commitment to technology to maintain their position at the forefront of the assisted reproduction field. They have a strong international reputation and treat patients from around the world.

www.ivf-spain.com

IGLS - Integrated Genetic Laboratory Services

IGLS is a Spanish laboratory, based in Alicante, with own R&D teams fully dedicated to providing testing and diagnostic services to medical centres and professionals of the assisted reproduction field worldwide. With a comprehensive service scope that englobes genetics, immunology and regenerative medicine, IGLS has the scientific and technical pedigree to ensure the continuous development of accurate solutions, thereby keeping the group abreast of industry trends.

www.igls.net

Nordic Capital

Nordic Capital is a leading private equity investor with a resolute commitment to creating stronger, sustainable businesses through operational improvement and transformative growth. Nordic Capital focuses on selected regions and sectors where it has deep experience and a long history. Focus sectors are Healthcare, Technology & Payments, Financial Services, and selectively, Industrial & Business Services. Key regions are Europe and globally for Healthcare and Technology & Payments investments. Since inception in 1989, Nordic Capital has invested close to EUR 22 billion in 130 investments. The committed capital is principally provided by international institutional investors such as pension funds. Nordic Capital Advisors have local offices in Sweden, the UK, the US, Germany, Denmark, Finland, Norway and South Korea. For further information about Nordic Capital, please visit www.nordiccapital.com.

The following files are available for download:

https://mb.cision.com/Main/22064/3683981/1734630.pdf

Care Fertility_press release_13th December 2022_final_pdf

https://news.cision.com/care-fertility/i/care-fertility-logo-rgb,c3126204

care fertility logo RGB

https://news.cision.com/care-fertility/i/alex-embryoscope,c3126205

alex-embryoscope

Cision View original content:https://www.prnewswire.co.uk/news-releases/care-fertility-group-expands-its-international-footprint-to-the-us-and-spain-301701804.html

© 2022 PR Newswire
Treibt Nvidias KI-Boom den Uranpreis?
In einer Welt, in der künstliche Intelligenz zunehmend zum Treiber technologischer Fortschritte wird, rückt auch der Energiebedarf, der für den Betrieb und die Weiterentwicklung von KI-Systemen erforderlich ist, in den Fokus.

Nvidia, ein Vorreiter auf dem Gebiet der KI, steht im Zentrum dieser Entwicklung. Mit steigender Nachfrage nach leistungsfähigeren KI-Anwendungen steigt auch der Bedarf an Energie. Uran, als Schlüsselkomponente für die Energiegewinnung in Kernkraftwerken, könnte dadurch einen neuen Stellenwert erhalten.

Dieser kostenlose Report beleuchtet, wie der KI-Boom potenziell den Uranmarkt beeinflusst und stellt drei aussichtsreiche Unternehmen vor, die von diesen Entwicklungen profitieren könnten und echtes Rallyepotenzial besitzen

Handeln Sie Jetzt!

Fordern Sie jetzt den brandneuen Spezialreport an und profitieren Sie von der steigenden Nachfrage, der den Uranpreis auf neue Höchststände treiben könnte.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.